by
Lisa Chamoff, Contributing Reporter | July 19, 2021
From the July 2021 issue of HealthCare Business News magazine
Micrima, which manufactures a breast scanning system that uses radio-waves instead of X-rays, is submitting its seventh-generation device for CE approval.
The latest version of the device has better sensitivity and is less reliant on expensive components, said Adrian Waller, the chief executive officer of Micrima.
The device, which Waller says shows high sensitivity for dense breast tissue, is currently used as a radiation-free adjunctive tool in the European market. The company’s goal in the next six to 12 months is to develop classifiers that will allow it to be used as a primary screening tool.
“Our mission is to help healthcare professionals save lives by detecting cancer earlier. We believe the best way to do this is to replace mammography in screening,” Waller said.
PenRad
In August, PenRad, which provides mammography tracking, reporting and compliance software, launched PenExpress, which allows patients to update their personal health history and complete high-risk and genetic testing eligibility documents from their home, prior to their appointment. Working in concert with PenConnect and PenForms, the patient gets a secure link and can complete the documentation, avoiding paper forms and crowded waiting rooms.
“PenRad clients report patients appreciate the opportunity to spend less time in waiting rooms, more time to do a thorough job of completing their risk history forms, and with PenConnect, receiving their exam result electronically the same day as their appointment,” said Daniel Bickford, marketing director for PenRad.
PenRad also recently partnered with Myriad Genetics to offer a high-risk and genetics screening package and streamlined patient access to Myriad’s genetic counselors for participating clinics.
Philips 24 inch HD MAX monitor display with Breast lesion 0380
Philips
This year, Philips updated its Ultimate Breast Solution by introducing Microflow Imaging High Definition (MFI HD), which provides twice the sensitivity and twice the resolution compared to legacy MFI, according to the company. Additionally, contrast imaging has been improved for breast application. These enhancements will extend the integrated breast solution using the Anatomical Intelligent Breast scanning assistant from Philips, which combines advanced imaging, full solution elastography and precision biopsy.
